ProSiebenSat.1 Media SE

CNTN completes Gravitas sale, refocuses strategy

Canton Strategic Holdings completed the sale of its Gravitas Life Sciences biotech unit to Gravitas Collective Corp, a deal approved by a special independent committee and closed in mid-July 2026, shifting the company away from biotech toward its Canton Network and digital-asset initiatives. The move aims to streamline operations, boost focus on digital assets and GV104, and is complemented by governance safeguards and a renewed emphasis on blockchain infrastructure, with insiders having minimal recent activity on the stock.